Hebei Changshan Biochemical Pharmaceutical (300255.SZ) Earnings Analysis
Hebei Changshan Biochemical Pharmaceutical (300255.SZ) has no confirmed upcoming earnings date. Trailing P/E -71.03.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 300255.SZ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 300255.SZ. This page updates as the calendar is published.
300255.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-10-30 | -0.01711 CNY | n/a | n/a | n/a |
| 2025-06-30 | -0.03563 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.0041 CNY | n/a | n/a | n/a |
| 2024-12-31 | -0.2781 CNY | n/a | n/a | n/a |
| 2024-09-29 | 0.05897 CNY | n/a | n/a | n/a |
300255.SZ valuation and analyst view
| Trailing P/E | -71.03 |
|---|---|
| Trailing EPS | -0.38787 CNY |
| Price / book | 20.80 |
| Dividend yield | 0.00% |
| Market cap | 26.16B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Hebei Changshan Biochemical Pharmaceutical (300255.SZ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 300255.SZ. This page updates as the calendar is published.
Did 300255.SZ beat earnings last quarter?
Consensus estimate data was not available for 300255.SZ's 2025-10-30 report.
What is 300255.SZ's current P/E ratio and EPS?
300255.SZ trades at a trailing P/E of -71.03 on trailing EPS of -0.38786543559819703 CNY.
What do analysts rate 300255.SZ?
300255.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.